ACUTE PULMONARY EMBOLISM TREATED WITH TISSUE PLASMINOGEN ACTIVATOR
- 18 October 1986
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 328 (8512), 886-889
- https://doi.org/10.1016/s0140-6736(86)90411-3
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion.Circulation, 1986
- Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial.Circulation, 1986
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.Circulation, 1984
- Thrombolysis, clot selectivity, and kinetics.Circulation, 1984
- Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial InfarctionNew England Journal of Medicine, 1984
- Effect of Thrombolytic Therapy on Pulmonary-Capillary Blood Volume in Patients with Pulmonary EmbolismNew England Journal of Medicine, 1980
- The sulphite precipitation method for fibrinogen measurement; Its use on small samples in the presence of fibrinogen degradation productsClinica Chimica Acta; International Journal of Clinical Chemistry, 1976
- Urokinase-streptokinase embolism trial. Phase 2 results. A cooperative studyPublished by American Medical Association (AMA) ,1974
- HypertensionCirculation, 1973